Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease.
Sorrentino
Dario
D
Terrosu
Giovanni
G
Vadalà
Salvatore
S
Avellini
Claudio
C
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D005355:Fibrosis; D006801:Humans; D000069285:Infliximab; D007415:Intestinal Obstruction / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab